Evidence is growing to support the idea that the immune system plays a role in some breast cancers and that tumour infiltrating lymphocytes (TILs) can predict prognosis and response to therapy. Given TILs can be easily estimated on hematoxylin and eosin stains, they offer a relatively simple biomarker that can potentially help direct therapy. According ...
TILs reveal the immune signal in breast cancer
By Mardi Chapman
17 Aug 2017